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and Sexual Functions in Menopausal Women
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Department of Urology, Inje University Busan Paik Hospital, Busan, Korea
Purpose: To investigate the impact of menopause on the quality of life (QoL) of mid-
dle-aged and older women, including their general well-being, voiding-related symp-
toms, and sexual distress.
Materials and Methods: To assess QoL, we administered a questionnaire that included 
questions about voiding-related symptoms and female sexual distress and part of the 
Women’s Health Questionnaire. The self-administered questionnaires were completed 
by 1,679 women in the Korea. Data for 1,262 women were available for analysis, includ-
ing premenopausal (n=307), perimenopausal (n=240), and postmenopausal (n=715) 
groups.
Results: Voiding-related discomfort increased significantly in perimenopausal and 
postmenopausal women compared with premenopausal women (p＜0.001). General 
well-being worsened as menopause progressed (p＜0.001). Menopausal women who 
were older (p=0.014), had a hysterectomy (p=0.005), or had urinary incontinence 
(p=0.001) had more voiding-related symptoms. Hypertension (p=0.026), cardiac dis-
ease (p=0.013), and arthritis (p=0.001) resulted in significantly decreased general 
well-being. Women with a hysterectomy (p=0.017) and those with arthritis (p=0.004) 
had high sexual distress. In the menopausal group, employed women had better general 
well-being than did unemployed women.
Conclusions: Menopause negatively affected the QoL of middle-aged and older women 
because of decreased general well-being and increased voiding-related symptoms. 
General health, even in menopausal women, was important to maintain a better QoL. 
To preserve the QoL of women undergoing menopause, control of menopause and under-
lying disease should be considered.
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INTRODUCTION
As people are living longer with advances in science, medi-
cine, and economic status, interest has transitioned from 
simply increasing longevity to improving the quality of life 
(QoL). Middle-aged and older women undergoing meno-
pause experience lifestyle changes. A postmenopausal 
woman with an erratic decline in ovarian steroid hor-
mones, especially estrogen and progesterone, experiences 
symptoms such as an irregular menstrual cycle, hot flash-
es, sleep disturbance, mood swings, voiding-related symp-
toms, and changes in sexual function. In the past, when life 
expectancy was less than 60 years, life after menopause 
was considered a blessing and postmenopausal symptoms 
were not considered seriously.
Gracia et al reported that numerous factors play roles in 
the sexual dysfunction encountered after menopause, in-
cluding the absence of a partner, high anxiety, children liv-
ing at home, and pain [1]. A low dehydroepiandrosterone 
sulfate (DHEAS) level was reported to correlate well with Korean J Urol 2011;52:858-864
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sexual dysfunction. Declining estrogen levels also contrib-
ute to changes in the lower urinary tract. For example, the 
urinary bladder and urethra may produce symptoms re-
lated to stress incontinence, urinary urgency, and 
frequency. Deterioration in the vaginal and periurethral 
tissue is called vaginal atrophy and decreased estrogen is 
the primary cause. From a psychiatric perspective, affected 
women are susceptible to decreased libido, depression, low 
back pain, and memory loss compared with their healthy 
counterparts, and they subsequently experience deterio-
rating health and a poor QoL.
Although many studies have examined the decline in 
physical and mental functions among postmenopausal 
women, few studies have reported on their overall QoL, in-
cluding lower urinary tract symptoms and sexual distress, 
as menopause progresses. Few studies have reported ob-
jective data for the effects of menopause on changes in uri-
nary habits, sexual stress, and general well-being, which 
led us to accumulate these important data on patient care 
in Korea.
This study investigated the effects of menopause on QoL, 
including general well-being, voiding-related symptoms, 
and sexual distress, and the correlations among these 
factors.
MATERIALS AND METHODS
The study subjects were 1,679 women aged 40 to 65 years 
in the general population. To avoid selecting patients with 
specific symptoms, we recruited lay people, including 816 
in Busan and Gyeongsangnam-do, 561 in Seoul and 
Gyeonggi-do, and 302 in Daegu and Gyeongsangnam-do.
After giving informed consent, the subjects completed a 
questionnaire. After excluding subjects who did not fall in-
to the target age range (40 to 65 years old) or did not answer 
every question, 1,262 subjects remained for analysis.
The subjects were categorized into premenopausal, peri-
menopausal, and postmenopausal groups. Perimenopause 
was defined as the state in which a woman had irregular 
periods or no periods in the past year. Postmenopause was 
defined as post-oophorectomy or the absence of menstru-
ation for more than 1 year.
The questionnaire comprised 30 subsets, including per-
sonal information, voiding-related symptoms, general 
well-being, and sexual distress. The personal information 
included questions on age, occupation, history of hyster-
ectomy, menstrual status, and medical conditions, includ-
ing diabetes mellitus (DM), hypertension (HTN), obesity, 
dyslipidemia, cancer, urinary incontinence, and arthritis. 
The subset of questions on voiding-related symptoms used 
five of the nine questions from the Korean version of the 
benign prostatic hypertrophy QoL questionnaire, an in-
strument developed by the Korean Urology Association in 
2001 to evaluate the QoL of patients with lower urinary 
tract symptoms [2]. Scores ranged from 1 to 6, with higher 
scores indicating worse voiding-related symptoms. To 
evaluate general well-being, we translated into Korean 
and validated 15 questions (scored 1-4) from the Woman’s 
Health Questionnaire developed by Hunter et al to eval-
uate the physical and psychological symptoms of peri- or 
postmenopausal patients [3]. Lower summed scores in-
dicated worse QoL. To obtain information about sexual 
function, we used the female sexual distress scale (FSDS) 
developed by Derogatis et al to assess the degree of stress 
associated with sexual life in the most recent 2 weeks [4]. 
For simplicity, we used five of the 12 questions after con-
firming their validity in Korean. Scores ranged from 1 to 
5, with higher scores indicating greater stress.
1. Statistical analysis
SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA) was used for 
the statistical analysis. Student’s t-test and ANOVA were 
used to analyze the voiding-related symptoms, general 
well-being, and sexual distress according to menopausal 
status and the severity of the voiding-related symptoms, 
general well-being, and sexual distress according to the 
employment status of the postmenopausal women. The as-
sociation of voiding-related symptoms, general well-being, 
and sexual distress with chronic disease in the post-
menopausal women was assessed by using a linear re-
gression model. We used the risk ratio with a 95% con-
fidence interval (CI) to evaluate the association between 
chronic disease and voiding-related symptoms, general 
well-being, and sexual distress. Beta is reported with the 
accompanying 95% CI. Results were considered statisti-
cally significant when p＜0.05.
RESULTS
The subjects included 375 (29.7%), 525 (41.6%), and 362 
(28.7%) women in their 40s, 50s, and 60s, respectively, with 
an average age of 54.9±8.4 years. According to menstrual 
status, the sample included 307 (24.3%), 240 (19%), and 
715 (56.7%) pre-, peri-, and postmenopausal women with 
average ages of 46.9±5.0, 50.7±4.7, and 59.8±7.0 years, 
respectively. The sample included 583 (46.2%) subjects 
with no underlying medical condition, 400 (31.7%) subjects 
with one disease, 162 (12.8%) with two diseases, 72 (5.7%) 
with three diseases, 29 (2.3%) with four diseases, and 16 
(1.4%) subjects with five or more diseases. In addition, 450 
(35.7%) subjects were employed and 812 (64.3%) were not 
(Table 1).
1. Voiding-related symptoms
A significant difference (ANOVA, p＜0.001) was observed 
among the average scores for voiding-related symptoms in 
the pre- (8.1±4.2), peri- (10.1±3.9), and postmenopausal 
(11.7±5.0) groups (Table 2).
2. General well-being
Total scores were 32.4±6.8, 39.1±5.4, and 37.1±6.5 in the 
pre-, peri-, and postmenopausal groups, respectively, con-
firming the decrease in general well-being as menopause 
progresses (ANOVA, p＜0.001) (Table 2).Korean J Urol 2011;52:858-864
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TABLE 1. Characteristics of 1,367 participants who completed 
the questionnaires
Characteristics
Age 
40-49
50-59
60-65
Mean age (yr)
Menstrual status
Premenopause
Perimenopause
Postmenopause
Hysterectomy state 
Combined disease 
None
1
2
3
4
5＜
Occupation 
Yes
No
375 (29.7)
525 (41.6)
362 (28.7)
54.9±8.4
307 (24.3)
240 (19.0)
715 (56.7)
132 (10.5)
583 (46.2)
400 (31.7)
162 (12.8)
72 (5.7)
29 (2.3)
16 (1.4)
450 (35.7)
812 (64.3)
Values are presented as number of patients or mean±SD with per-
centage in parenthesis
TABLE 2. ANOVA of voiding-related symptoms, general well-being, and sexual distress according to menstrual state
Premenopausal group Perimenopausal group Postmenopausal group
p-value
nM e a n ± S D nM e a n ± S D nM e a n ± S D
Age
Voiding-related symptoms
General well-being
Sexual distress
307
307
307
307
46.9±5.0
a
  8.1±4.2
a
32.4±6.8
a
10.9±3.7
240
240
240
240
50.7±4.7
b
10.1±3.9
b
39.1±5.4
b
11.2±4.0
715
715
715
715
59.8±7.0
c
11.7±5.0
c
37.1±6.5
c
12.7±4.4
0.001
0.001
0.001
0.318
a,b,c:
 Post hoc test by scheffe (p＜0.001)
TABLE 3. Correlation between voiding-related symptoms and 
sexual distress according to menstrual state
n
Lower 
score
Higher 
score p-value
Mean±SD Mean±SD
Premenopausal group
Perimenopausal group
Postmenopausal group
207
240
715
10.5±4.04
10.3±4.14
  9.7±6.37
11.0±4.84
12.9±5.50
11.0±6.82
0.652
0.001
0.010
Lower score (5-14), higher score (15-30)
3. Sexual distress
The average score for sexual distress tended to increase 
from 10.9±3.7 to 11.5±4.0 to 12.7±4.4 in the pre-, peri-, and 
postmenopausal groups, respectively (ANOVA, p=0.318) 
(Table 2), although the differences were not significant.
4. Voiding-related symptoms, general well-being, and sex-
ual distress in premenopausal and postmenopausal 
groups according to age
Among women aged 40 to 44, 45 to 49, and over 50 years 
in the premenopausal group, no statistical significance 
was demonstrated in voiding-related symptoms (p=0.614) 
or general well-being (p=0.555). Among women in the post-
menopausal group aged under 50, 50 to 59, and over 60 
years, statistical significance was demonstrated for void-
ing-related symptoms (p=0.009) and general well-being 
(p=0.015). 
5. Voiding-related symptoms, general well-being, and sex-
ual distress according to menstrual status in women 
aged 50 to 55 years
The number of premenopausal, perimenopausal, and post-
menopausal women aged 50 to 55 years was 61,104, and 
170, respectively. Among women in these groups, the stat-
istical significances in the parameters of voiding-related 
symptoms and general well-being were p=0.000 and 
p=0.020, respectively.
6. Correlation between voiding-related symptoms and sex-
ual function according to menstrual status
The menopausal groups were subdivided into two groups 
on the basis of the average scores for questions in the sexual 
domain (15-30 vs. 5-14). The higher subgroup had a sig-
nificantly higher score in the urinary domain than did the 
lower subgroup (11.0±6.82 vs. 9.7±6.37, p=0.010). In the 
premenopausal group, no correlation was found between 
the subgroups with high and low scores (11.0±4.84 vs. 
10.5±4.04, p=0.652). In contrast, a significant difference 
was observed between the high- and low-scoring peri-
menopausal subgroups (12.9±5.50 vs. 10.3±4.14, p=0.001) 
(Table 3).
7. Quality of life and medical conditions in the postmeno-
pausal group
We found significant correlations between voiding-related 
symptoms and old age (p=0.037), a previous hysterectomy 
(p＜0.001), cardiac disease (p=0.041), obesity (p=0.004), 
urinary incontinence (p＜0.001), and arthritis (p=0.006). 
Multivariate analysis showed correlations with age 
(p=0.014, 95% CI: -0.121, -0.014), a previous hysterectomy 
(p=0.002, 95% CI: -2.770, -0.602), obesity (p=0.012, 95% CI: Korean J Urol 2011;52:858-864
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TABLE 4. Univariate analysis of voiding-related symptoms according to medical conditions in the group of postmenopausal women
Voiding-related symptoms General well-being Sexual distress
β p-value β p-value β p-value
Age
Hysterectomy state
Diabetes mellitus
Hypertension
Cardiac disease
Obesity
Hyperlipidemia
Malignancy
Urinary incontinence
Arthritis
-0.078
-0.139
0.075
0.031
0.076
0.108
0.041
0.049
0.212
0.103
0.037
＜0.001
0.044
0.409
0.041
0.004
0.276
0.187
＜0.001
0.006
-0.035
＜0.001
-0.057
-0.104
-0.108
-0.013
-0.043
-0.025
-0.023
-0.162
0.344
0.992
0.127
0.006
0.004
0.737
0.247
0.502
0.541
0.001
-0.029
-0.084
-0.051
-0.058
-0.021
0.061
0.062
-0.004
0.082
-0.087
0.432
0.025
0.169
0.122
0.570
0.106
0.100
0.913
0.029
0.020
TABLE 5. Multivariate analysis of general well-being according to medical conditions in the group of postmenopausal women
Voiding-related symptoms General well-being Sexual distress
β p-value 95% CI β p-value 95% CI β p-value 95% CI
Age
Hysterectomy state
Diabetes mellitus
Hypertension
Cardiac disease
Obesity
Hyperlipidemia
Malignancy
Urinary incontinence
Arthritis
-0.090
-0.111
0.060
0.021
0.059
0.093
-
0.006
0.027
0.193
0.057
0.014
0.002
0.110
0.572
0.110
0.012
0.874
0.473
＜0.001
0.124
-0.121-
-0.014
-2.770-
-0.602
-0.245-
2.417
-1.175-
0.650
-0.251-
2.463
0.266-
2.141
-1.244-
1.058
-1.642-
3.534
1.967-
4.362-
-0.182-
1.502
-0.417
-0.349
-0.955
-2.090
-2.348
0.321
-0.418
0.042
0.543
-4.082
0.677
0.727
0.640
0.037
0.019
0.748
0.676
0.967
0.587
＜0.001
-0.106-
0.069
-2.069-
1.444
-3.206-
-1.107
-3.051-
-0.095
-4.827-
-0.430
-1.271-
1.768
-2.262-
1.467
-4.103-
4.282
-1.403-
2.477
-4.190-
-1.471
-0.023
-0.088
-0.056
-0.064
-0.021
0.66
0.62
0.10
-0.093
-0.108
0.547
0.019
0.143
0.094
0.569
0.082
0.103
0.783
0.015
0.005
-0.089-
0.047
-3.025-
-0.271
-2.953-
-0.429
-2.149-
0.169
-2.224-
1.223
-0.133-
2.249
-0.248-
2.676
-2.826-
3.748
0.370-
3.412
-2.617-
0.480
CI: confidence interval 
0.266, 2.141), and urinary incontinence (p＜0.001, 95% CI: 
1.967, 4.362). General well-being was correlated with HTN 
(p=0.006), cardiac disease (p=0.004), and arthritis (p
＜0.001). In the multivariate analysis, HTN (p=0.037, 95% 
CI: -3.206, 1.107), cardiac disease (p=0.019, 95% CI: -4.827, 
-0.430), and arthritis (p＜0.001, 95% CI: -4.190, -1.471) 
were all correlated. Sexual distress was related to a pre-
vious hysterectomy (p=0.025), urinary incontinence 
(p=0.029), and arthritis (p=0.020); the multivariate analy-
sis showed correlations with previous hysterectomy 
(p=0.019, 95% CI: -3.025, -0.271), urinary incontinence 
(p=0.015, 95% CI: 0.370, 3.412), and arthritis (p=0.005, 
95% CI: -2.617, -0.480) (Tables 4, 5).
8. Quality of life and employment in the postmenopausal 
group
Despite having gone through menopause, women who 
were employed had a higher QoL score than did those who 
were unemployed (36.1±6.46 vs. 37.6±6.52, p=0.001). 
Sexual distress (11.1±4.80 vs. 9.96±6.93, p=0.084) and 
voiding-related symptoms (11.5±5.0 vs. 12.17±5.35, p= 
0.162) (Fig. 1) were not correlated with employment status.
DISCUSSION
This study examined postmenopausal symptoms in mid-
dle-aged women in Korea to prepare for the aging of society 
by understanding the effects of menopause on QoL, espe-
cially in terms of voiding-related symptoms, sexual func-Korean J Urol 2011;52:858-864
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FIG. 1. Symptom severity of voiding-related symptoms, general 
well-being, and sexual distress according to the employment 
state in the group of postmenopausal women (
ap＜0.05). QoL: 
quality of life.
tion, and general well-being. The subjects were divided into 
pre-, peri-, and postmenopausal groups and were ad-
ministered a questionnaire to evaluate the impact of the 
progression of menopause. We restricted the study sub-
jects to the age range of 40 to 65 years to minimize the influ-
ence of age. Obviously, the average age in the three groups 
differed (p＜0.001), implying that the effect of menopause 
on the QoL of middle-aged women is closely related to the 
physical aging process.
Voiding difficulty worsened as the women went through 
menopause. Scores for three questions about lower urinary 
tract symptoms and the two about physical conditions in-
creased with the progression through menopause. Physio-
logically, estrogen receptors are present in the proximal 
and distal urethra, vagina, and trigonal epithelium of the 
urinary bladder. The lack of estrogen after menopause can 
cause dysfunction of bladder contraction and urethral clo-
sure by affecting the circulation to the urethra, which de-
creases pressure and contributes to incontinence [5-7]. In 
addition, estrogen would relieve voiding-related symp-
toms, including urgency, frequency, and urge incontinence 
[8].
The questionnaire on general well-being included ques-
tions about depressive mood (3), vasomotor symptoms (3), 
attractiveness (1), somatic symptoms (4), memory and con-
centration (1), and sexual behavior (3). Responses to these 
questions showed that the QoL decreased as menopause 
progressed. This decline is thought to be secondary to the 
physical and psychological changes due to the reduction in 
hormones after menopause. As Freeman's study indicated, 
depressive symptoms worsen as women enter the peri-
menopausal period. Significant predictors of depressive 
symptoms include a history of depression, severe premen-
strual syndrome, poor sleep, age, race, and employment 
status [9].
The original FSDS questionnaire comprised 20 ques-
tions, of which 16 dealt with single factors, such as dissat-
isfaction, anger, concern, and disappointment. Others 
measured different aspects, such as a bad sexual relation-
ship and anxiety regarding sexual performance. We used 
one question each about sexual performance, stress, dis-
satisfaction, anger, and loss of sexual attraction, but did not 
include sexual performance, because it does not seem to be 
a good measure of whether sexual problems exist [5]. When 
we included all of these measures, sexual stress did not 
seem to be influenced by menopause. However, the ques-
tionnaire on general well-being suggested that physical 
sexual activity contributed to general well-being in the 
pre-, peri-, and postmenopausal groups (ANOVA, p＜ 
0.001). 
Because these groups were composed of women of differ-
ent ages, age could have affected the parameters as well as 
menopause. Therefore, we tried to verify the statistical sig-
nificance of the parameters affected by menopause, not by 
age. We subanalyzed the statistical significance in void-
ing-related symptoms and general well-being in the pre-
menopausal and postmenopausal groups according to age, 
which showed statistical significance except for sexual 
distress. We also analyzed the parameters among pre-
menopausal, perimenopausal, and postmenopausal wom-
en aged 50 to 55 years. This analysis demonstrated stat-
istical significance in the parameters of voiding-related 
symptoms and general well-being. These 3 subanalyses 
supported the finding that menopause rather than age sig-
nificantly affected voiding-related symptoms and general 
well-being, although age was one of the factors to more ad-
versely affect voiding-related symptoms in the older aged 
group.
We postulate that although physical discomfort may be 
worse, a decrease in sexual desire may contribute to re-
duced psychological stress. In addition, one should consid-
er cultural factors when interpreting sexually related 
matters. In a study of women who had surgically induced 
menopause and lacked ovarian hormones, Graziottin et al 
found that 35% to 44% of the women had disordered sexual 
desire [10,11]. Up to 87% of elderly women have been re-
ported to complain of sexual dissatisfaction [12]. In at-
tempts to treat sexual desire disorder, testosterone and es-
trogen replacement are effective in the short term for dis-
orders of desire, arousal, and orgasm; vaginal estrogen tab-
lets to correct the physical component might be effective in 
treating symptoms due to vaginal atrophy, the pH of the 
vagina, and the vaginal maturation index [13,14].
Voiding-related symptoms were prominent in meno-
pausal women who were older, had a previous hyster-
ectomy, were obese, and had urinary incontinence. As men-
tioned, the physical aging process is associated with void-
ing-related symptoms, and the loss of bladder support sec-
ondary to a hysterectomy can contribute to such symptoms. 
A recent study found a correlation between DM and void-
ing-related symptoms, although the correlation was not Korean J Urol 2011;52:858-864
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significant, perhaps because the study did not examine the 
severity or duration of DM. The general-well being was 
worse in patients with HTN, cardiac disease, and arthritis; 
physical restrictions, rather than DM, obesity, or dyslipi-
demia, may contribute to the QoL [15]. Patients with a dis-
order of the genital tract, such as a hysterectomy or con-
nective-tissue disorder, may have limited movement of the 
large joints during intercourse that restricts the positions 
they can assume and may have a negative body image, all 
of which might negatively affect their sexual life [16]. As 
with the results for voiding-related symptoms, DM was not 
correlated with sexual distress in this study.
In the menopausal group, employed women expressed 
greater satisfaction in the assessment of QoL, but sexual 
distress was not affected by employment. Our results dif-
fered from those of previous studies. In a Turkish study, 
employed women of all ages had low sexual dysfunction. 
Moreover, the Turkish subjects in the same age range as 
examined in our study showed a low prevalence of sexual 
dysfunction [17]. This discrepancy might be explained by 
a cultural difference in terms of whether women consider 
reduced sexual desire a problem. In the menopausal group, 
employment did not contribute to voiding-related 
symptoms. The EPIC study, which compared subjects with 
overactive bladders to those without symptoms, found a 
significant difference in the effect of employment [18]. In 
contrast, employment in Korean women had no effect on 
lower urinary tract symptoms, although patients with 
voiding-related problems may need these to be corrected 
because they could reduce performance and productivity 
at work.
Our subdivision of menopausal women into high- and 
low-scoring subgroups for voiding-related symptoms re-
vealed that worse voiding-related symptoms were asso-
ciated with greater sexual dysfunction. The dysfunction 
was related more to the combination of an overactive blad-
der with voiding-related symptoms, rather than an over-
active bladder alone or an overactive bladder with urge in-
continence alone. An improvement in voiding-related 
symptoms might correct the sexual dysfunction experi-
enced by menopausal women.
There are several limitations to this study. First, we 
would have preferred to recruit subjects nationwide but 
were limited to recruiting subjects from a few metropolitan 
areas. Consequently, we cannot exclude the possibility 
that socioeconomic and educational backgrounds might 
have affected the results. In addition, the use of a ques-
tionnaire, rather than in-depth interviews, to collect data 
might have affected the validity of our study.
CONCLUSIONS
Menopause in Korean females has a negative impact on 
voiding-related symptoms and general well-being but not 
on sexual distress. Nevertheless, in the menopausal group, 
worsening voiding-related symptoms strongly affected 
sexual distress. Underlying medical conditions can de-
crease QoL. In general, employed subjects, even meno-
pausal women, had better well-being. In conclusion, it 
might be necessary to control physical symptoms, treat un-
derlying medical conditions, and encourage subjects to 
take an active attitude toward life to improve the QoL of 
middle-aged women.
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